Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Unfavorable outcomes in pediatric PAX5r B-cell precursor acute lymphoblastic leukemia: FLT3 targeting as a potential novel treatment strategy

Blood (2025) 146 (Supplement 1): 760.

https://doi.org/10.1182/blood-2025-760

Published: 2025

Journal Articles

Next generation sequencing profiling of pediatric Acute Myeloid Leukemia reveals distinct genetic landscapes across cytogenetic subgroups

Maddalena Benetton, Claudia Tregnago, Katia Polato, Diego Calvetti, Veronica Zampieri, Manuela Tumino, Barbara Buldini, Alessandra Biffi, Valeria Paganelli, Pietro Merli, Giuseppe Menna, Franca Fagioli, Carmelo Rizzari, Franco Locatelli, Martina Pigazzi

Blood (2025) 146 (Supplement 1): 5268.

https://doi.org/10.1182/blood-2025-5268

Published: 2025

Journal Articles

CD48 as an additional marker for measurable residual disease assessment in pediatric Acute Myeloid Leukemia.

Margarita Maurer-Granofszky, Elena Varotto, Dagmar Schinnerl, Pamela Scarparo, Sabine Strehl, Barbara Buldini, Michael Dworzak

Blood (2025) 146 (Supplement 1): 1741.

https://doi.org/10.1182/blood-2025-1741

Published: 2025

Journal Articles

Chemotherapy-free treatment for children and adolescents with newly diagnosed acute promyelocytic leukemia (APL): Results of the prospective ICC-APL-02 study.

Blood (2025) 146 (Supplement 1): 880.

https://doi.org/10.1182/blood-2025-880

Published: 2025

Journal Articles

Clinical, cytogenetic and molecular characteriszation of Mecom- rearranged pediatric de novo Acute Myeloid Leukemia (AML): A retrospective cohort study of the international-berlin-frankfurt-Münster (I-BFM) AML-study group

Blood (2025) 146 (Supplement 1): 1608.

https://doi.org/10.1182/blood-2025-1608

Published: 2025

Journal Articles

A novel intercontinental external quality assessment program for flow cytometric measurable residual disease assessment in pediatric AML

Blood (2025) 146 (Supplement 1): 3514.

https://doi.org/10.1182/blood-2025-3514

Published: 2025

Journal Articles

A single cell multiomic approach to dissect immunophenotypic plasticity in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) pediatric patients

Giulia Gomiero, Alberto Peloso, Elena Varotto, Pamela Scarparo, Chiara Frasson, Alice Cani, Grazia Fazio, Giovanni Cazzaniga, Franco Locatelli, Carmelo Rizzari, Alessandra Biffi, Michael Dworzak, Silvia Bresolin, Barbara Buldini

Blood (2025) 146 (Supplement 1): 36.

https://doi.org/10.1182/blood-2025-36

Published: 2025

Journal Articles

Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel

Blood blood.2024027904.

https://doi.org/10.1182/blood.2024027904

Published: 2025

Includes: Supplemental data

Journal Articles

Frequency and Early Prognostic Significance of Gene-Class Fusions Identified By RNA-Seq in Children and Adolescent with T-Cell Acute Lymphoblastic Leukemia Enrolled on AIEOP-BFM ALL 2017 Study

Blood (2024) 144 (Supplement 1): 4217.

https://doi.org/10.1182/blood-2024-207345

Published: 2024

Journal Articles

CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

Luciana Vinti, Jolanda Pianese, Elisa Carraro, Paola Muggeo, Daniela Onofrillo, Irene d'Alba, Elisabetta Schiavello, Raffaella De Santis, Concetta Micalizzi, Veronica Barat, Katia Perruccio, Luca Lo Nigro, Barbara Buldini, Lara Mussolin, Valentina Bertaina, Rita de Vito, Marta Pillon, Franco Locatelli

Blood (2024) 144 (Supplement 1): 3086.

https://doi.org/10.1182/blood-2024-208728

Published: 2024

Journal Articles

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Ambra Da Ros, Alberto Peloso, Giorgia Longo, Maddalena Benetton, Valentina Indio, Stefano Cairo, Monica Sandri, Barbara Buldini, Silvia Bresolin, Antonio Rosato, Andrea Pession, Claudia Tregnago, Franco Locatelli, Martina Pigazzi

Blood (2024) 144 (Supplement 1): 2910.

https://doi.org/10.1182/blood-2024-200132

Published: 2024

Journal Articles

Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

Blood (2024) 144 (Supplement 1): 730.

https://doi.org/10.1182/blood-2024-201936

Published: 2024

Journal Articles

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Blood (2024) 143 (17): 1738–1751.

https://doi.org/10.1182/blood.2023021952

Published: 2024

Includes: Supplemental data

Journal Articles

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

Blood (2024) 143 (3): 279–289.

https://doi.org/10.1182/blood.2023021336

Published: 2024

Includes: Supplemental data

Journal Articles

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

Franco Locatelli, Barbara Buldini, Martina Pigazzi, Carmelo Rizzari, Rosanna Cuccurullo, Franca Fagioli, Manuela Tumino, Luca Lo Nigro, Maria Giuseppina Cefalo, Luisa Strocchio, Marco Zecca, Marco Becilli, Andrea Pession, Nicola Santoro, Concetta Micalizzi, Riccardo Masetti, Pietro Merli

Blood (2023) 142 (Supplement 1): 728.

https://doi.org/10.1182/blood-2023-188682

Published: 2023

Journal Articles

The Transcription Factors NFATc1 and NFATc2 Control Glucocorticoid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia

Giulia Veltri, Alberto Peloso, Alice Cani, Elena Mariotto, Giulia Borile, Loris Russo, Chiara Frasson, Matilde Cescon, Egidio Iorio, Sonia Minuzzo, Panagiotis Ntziachristos, Alessandra Biffi, Barbara Buldini, Martina Pigazzi, Stefano Indraccolo, Silvia Bresolin, Valentina Serafin

Blood (2023) 142 (Supplement 1): 420.

https://doi.org/10.1182/blood-2023-181548

Published: 2023

Journal Articles

Characterization of the Molecular Landscape of Pediatric Acute Myeloid Leukemia: A Retrospective AIEOP AML2013/01 Study

Maddalena Benetton, Pietro Merli, Nicola Santoro, Luca Lo Nigro, Claudia Tregnago, Ambra Da Ros, Katia Polato, Veronica Zampieri, Barbara Michielotto, Samuela Francescato, Anna Leszl, Riccardo Masetti, Barbara Buldini, Alessandra Biffi, Franca Fagioli, Carmelo Rizzari, Franco Locatelli, Martina Pigazzi

Blood (2023) 142 (Supplement 1): 1580.

https://doi.org/10.1182/blood-2023-186458

Published: 2023

Journal Articles

Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

Barbara Buldini, Pietro Merli, Elena Varotto, Riccardo Masetti, Maria Gabelli, Marco Zecca, Franca Fagioli, Pamela Scarparo, Mattia Algeri, Alessandra Biffi, Martina Pigazzi, Daria Pagliara, Franco Locatelli

Blood (2023) 142 (Supplement 1): 1590.

https://doi.org/10.1182/blood-2023-189080

Published: 2023

Journal Articles

Plasma S-Evs Mirnas in Pediatric B Lineage Leukemia: Transforming Factors of Bone Marrow Niche

Alice Cani, Carlotta Caterina Damanti, Federica Lovisa, Enrico Gaffo, Giulia Borile, Elisa Carraro, Pina Fusco, Elena Varotto, Stefania Bortoluzzi, Alessandra Biffi, Barbara Buldini, Carmelo Rizzari, Marta Pillon, Lara Mussolin, Silvia Bresolin

Blood (2023) 142 (Supplement 1): 4081.

https://doi.org/10.1182/blood-2023-188680

Published: 2023

Journal Articles

STAG2/LMO2 Gamma-Delta (γδ) T-ALL: Identification and Characterization of an Extremely High Risk Group of T-ALL in the Very Young

Shunsuke Kimura, Petri Pölönen, Lindsey Montefiori, Kenneth Caldwell, Ilaria Iacobucci, Chelsey Chen, Anthony Brown, Katie Han, Yen-Chun Liu, Yunchao Chang, Zhongshan Cheng, Zhou Yinmei, Chun Shik Park, Sharnise Mitchell, Noemi Reyes, Allen Yeoh, Andishe Attarbaschi, Andrew Moore, Atsushi Manabe, Barbara Buldini, Kean Hui Chiew, Chi Kong Li, Ching-Hon Pui, Chunxu Qu, Daisuke Tomizawa, Elisabeth Paietta, Franco Locatelli, Gabriele Escherich, Gao Qingsong, Hannah Elisa Muhle, Hanne Vibeke Marquart, Hester A. de Groot-Kruseman, Jacob M. Rowe, Jan Stary, Jan Trka, John Kim Choi, Jules P.P. Meijerink, Junko Takita, Katarzyna Pawinska-Wasikowska, Kjeld Schmiegelow, Mariko Eguchi, Martin Schrappe, Martin Zimmermann, Masatoshi Takagi, Melissa Maybury, Michael Svaton, Michaela Reiterova, Michal Kicinski, Motohiro Kato, Orietta Spinelli, Pauline Mazilier, Paul G. Thomas, Riccardo Masetti, Rishi Sury Kotecha, Rob Pieters, Sarah Elitzur, Selina M Luger, Shuhong Shen, Sima Jeha, Steven M. Kornblau, Szymon Skoczen, Takako Miyamura, Tiffaney Vincent, Toshihiko Imamura, Valentino Conter, Yanjing Tang, Zhaohui Gu, Kathryn G. Roberts, David T. Teachey, Kristine R Crews, Cheng Cheng, Jun J. Yang, Hiroto Inaba, Charles G. Mullighan

Blood (2023) 142 (Supplement 1): 845.

https://doi.org/10.1182/blood-2023-178688

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Unfavorable outcomes in pediatric PAX5r B-cell precursor acute lymphoblastic leukemia: FLT3 targeting as a potential novel treatment strategy

Next generation sequencing profiling of pediatric Acute Myeloid Leukemia reveals distinct genetic landscapes across cytogenetic subgroups

CD48 as an additional marker for measurable residual disease assessment in pediatric Acute Myeloid Leukemia.

Chemotherapy-free treatment for children and adolescents with newly diagnosed acute promyelocytic leukemia (APL): Results of the prospective ICC-APL-02 study.

Clinical, cytogenetic and molecular characteriszation of Mecom- rearranged pediatric de novo Acute Myeloid Leukemia (AML): A retrospective cohort study of the international-berlin-frankfurt-Münster (I-BFM) AML-study group

A novel intercontinental external quality assessment program for flow cytometric measurable residual disease assessment in pediatric AML

A single cell multiomic approach to dissect immunophenotypic plasticity in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) pediatric patients

Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel

Frequency and Early Prognostic Significance of Gene-Class Fusions Identified By RNA-Seq in Children and Adolescent with T-Cell Acute Lymphoblastic Leukemia Enrolled on AIEOP-BFM ALL 2017 Study

CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

The Transcription Factors NFATc1 and NFATc2 Control Glucocorticoid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia

Characterization of the Molecular Landscape of Pediatric Acute Myeloid Leukemia: A Retrospective AIEOP AML2013/01 Study

Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

Plasma S-Evs Mirnas in Pediatric B Lineage Leukemia: Transforming Factors of Bone Marrow Niche

STAG2/LMO2 Gamma-Delta (γδ) T-ALL: Identification and Characterization of an Extremely High Risk Group of T-ALL in the Very Young

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only